Skip to main content
eScholarship
Open Access Publications from the University of California

Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.

  • Author(s): Moughon, Diana L
  • He, Huanhuan
  • Schokrpur, Shiruyeh
  • Jiang, Ziyue Karen
  • Yaqoob, Madeeha
  • David, John
  • Lin, Crystal
  • Iruela-Arispe, M Luisa
  • Dorigo, Oliver
  • Wu, Lily
  • et al.

Published Web Location

http://cancerres.aacrjournals.org/content/canres/75/22/4742.full.pdf
No data is associated with this publication.
Abstract

Malignant ascites is a common complication in the late stages of epithelial ovarian cancer (EOC) that greatly diminishes the quality of life of patients. Malignant ascites is a known consequence of vascular dysfunction, but current approved treatments are not effective in preventing fluid accumulation. In this study, we investigated an alternative strategy of targeting macrophage functions to reverse the vascular pathology of malignant ascites using fluid from human patients and an immunocompetent murine model (ID8) of EOC that mirrors human disease by developing progressive vascular disorganization and leakiness culminating in massive ascites. We demonstrate that the macrophage content in ascites fluid from human patients and the ID8 model directly correlates with vascular permeability. To further substantiate macrophages' role in the pathogenesis of malignant ascites, we blocked macrophage function in ID8 mice using a colony-stimulating factor 1 receptor kinase inhibitor (GW2580). Administration of GW2580 in the late stages of disease resulted in reduced infiltration of protumorigenic (M2) macrophages and dramatically decreased ascites volume. Moreover, the disorganized peritoneal vasculature became normalized and sera from GW2580-treated ascites protected against endothelial permeability. Therefore, our findings suggest that macrophage-targeted treatment may be a promising strategy toward a safe and effective means to control malignant ascites of EOC.

Item not freely available? Link broken?
Report a problem accessing this item